Sysmex (OTCMKTS:SSMXY) Shares Down 3.2% - What's Next?

Key Points

• Shares of Sysmex Corporation have declined by 3.2%, trading between $12.67 and $12.93, with a volume increase to approximately 183,439 shares.
• Analysts have upgraded Sysmex's rating from "strong sell" to "hold", although the company reported lower-than-expected earnings, missing estimates by $0.07.
• Despite recent stock performance, Sysmex has a market cap of $8.14 billion and maintains strong liquidity ratios, with a quick ratio of 2.30 and a debt-to-equity ratio of 0.12.

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) were down 3.2% during trading on Monday . The stock traded as low as $12.67 and last traded at $12.93. Approximately 183,439 shares were traded during trading, an increase of 94% from the average daily volume of 94,580 shares. The stock had previously closed at $13.36.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Hold".

Sysmex Trading Down 3.2%

The company has a market cap of $8.14 billion, a PE ratio of 25.86 and a beta of 1.15. The company has a quick ratio of 2.30, a current ratio of 2.97 and a debt-to-equity ratio of 0.12. The business has a 50-day simple moving average of $15.97 and a 200-day simple moving average of $17.32.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). The firm had revenue of $717.09 million during the quarter, compared to analysts' expectations of $807.27 million. Sysmex had a net margin of 9.35% and a return on equity of 10.36%. On average, analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.